Skye Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Skye Bioscience, Inc. (SKYE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 4.35 million shares for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2022-11-14
- Skye Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-06-30 was 4.35M shares.
- Skye Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-03-31 was 0.00 shares.
- Skye Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-09-30 was 1.77M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 4.35M shares derived: sum of 2 quarters · filed 2022-11-14 | 4.35M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 4.35M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 4.35M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-06 | ||
| 2021-09-30 | 1.77M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 2.48M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 700.00K shares 10-Q · filed 2021-08-06 | ||
| 2015-03-31 | 1.77M shares 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |